JP2004519488A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519488A5
JP2004519488A5 JP2002571051A JP2002571051A JP2004519488A5 JP 2004519488 A5 JP2004519488 A5 JP 2004519488A5 JP 2002571051 A JP2002571051 A JP 2002571051A JP 2002571051 A JP2002571051 A JP 2002571051A JP 2004519488 A5 JP2004519488 A5 JP 2004519488A5
Authority
JP
Japan
Prior art keywords
composition
nicotinic acid
acid ester
subject
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002571051A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519488A (ja
JP5057353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/007256 external-priority patent/WO2002072092A1/en
Publication of JP2004519488A publication Critical patent/JP2004519488A/ja
Publication of JP2004519488A5 publication Critical patent/JP2004519488A5/ja
Application granted granted Critical
Publication of JP5057353B2 publication Critical patent/JP5057353B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002571051A 2001-03-08 2002-03-08 ニコチン酸化合物を使用するレプチンレベル増大のための方法 Expired - Fee Related JP5057353B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27434901P 2001-03-08 2001-03-08
US60/274,349 2001-03-08
PCT/US2002/007256 WO2002072092A1 (en) 2001-03-08 2002-03-08 Method for increasing leptin levels using nicotinic acid compounds

Publications (3)

Publication Number Publication Date
JP2004519488A JP2004519488A (ja) 2004-07-02
JP2004519488A5 true JP2004519488A5 (https=) 2005-12-22
JP5057353B2 JP5057353B2 (ja) 2012-10-24

Family

ID=23047813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571051A Expired - Fee Related JP5057353B2 (ja) 2001-03-08 2002-03-08 ニコチン酸化合物を使用するレプチンレベル増大のための方法

Country Status (12)

Country Link
US (2) US6750234B2 (https=)
EP (1) EP1365762B1 (https=)
JP (1) JP5057353B2 (https=)
CN (1) CN1265792C (https=)
AT (1) ATE409037T1 (https=)
CA (1) CA2437844C (https=)
DE (1) DE60229041D1 (https=)
DK (1) DK1365762T3 (https=)
ES (1) ES2315358T3 (https=)
MX (1) MXPA03008096A (https=)
PT (1) PT1365762E (https=)
WO (1) WO2002072092A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
WO2002009639A2 (en) 2000-07-31 2002-02-07 Bar Ilan University Methods and pharmaceutical compositions for healing wounds
WO2002072092A1 (en) * 2001-03-08 2002-09-19 University Of Kentucky Method for increasing leptin levels using nicotinic acid compounds
JP5204947B2 (ja) * 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
US7218948B2 (en) 2003-02-24 2007-05-15 Qualcomm Incorporated Method of transmitting pilot tones in a multi-sector cell, including null pilot tones, for generating channel quality indicators
US8811348B2 (en) 2003-02-24 2014-08-19 Qualcomm Incorporated Methods and apparatus for generating, communicating, and/or using information relating to self-noise
US9544860B2 (en) 2003-02-24 2017-01-10 Qualcomm Incorporated Pilot signals for use in multi-sector cells
WO2005013885A2 (en) 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
WO2006044718A2 (en) 2004-10-14 2006-04-27 Flarion Technologies, Inc. Methods and apparatus for determining, communicating and using information which can be used for interference control purposes
US8503938B2 (en) 2004-10-14 2013-08-06 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information including loading factors which can be used for interference control purposes
JP2006253769A (ja) * 2005-03-08 2006-09-21 National Institute Of Advanced Industrial & Technology 情報処理システムおよび方法
CN103127111B (zh) * 2005-06-24 2016-02-10 代表亚利桑那大学的亚利桑那校董会 用于治疗头发生长病症比如女性型脱发的方法及可用于此的组合物
EP2462944A3 (en) 2005-08-29 2012-09-12 HealOr Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
US20070066512A1 (en) * 2005-09-12 2007-03-22 Dominique Verhelle Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
US8989084B2 (en) 2005-10-14 2015-03-24 Qualcomm Incorporated Methods and apparatus for broadcasting loading information corresponding to neighboring base stations
US9191840B2 (en) 2005-10-14 2015-11-17 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information which can be used for interference control
US8437251B2 (en) 2005-12-22 2013-05-07 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US7801589B2 (en) 2005-12-22 2010-09-21 Olympus Corporation In-vivo examination method and in-vivo examination apparatus
US9119220B2 (en) 2005-12-22 2015-08-25 Qualcomm Incorporated Methods and apparatus for communicating backlog related information
US9125093B2 (en) 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus related to custom control channel reporting formats
US9148795B2 (en) 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
US9451491B2 (en) 2005-12-22 2016-09-20 Qualcomm Incorporated Methods and apparatus relating to generating and transmitting initial and additional control information report sets in a wireless system
US9125092B2 (en) 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus for reporting and/or using control information
US9572179B2 (en) 2005-12-22 2017-02-14 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US9137072B2 (en) 2005-12-22 2015-09-15 Qualcomm Incorporated Methods and apparatus for communicating control information
US9338767B2 (en) 2005-12-22 2016-05-10 Qualcomm Incorporated Methods and apparatus of implementing and/or using a dedicated control channel
US8514771B2 (en) 2005-12-22 2013-08-20 Qualcomm Incorporated Methods and apparatus for communicating and/or using transmission power information
US20070253449A1 (en) 2005-12-22 2007-11-01 Arnab Das Methods and apparatus related to determining, communicating, and/or using delay information
US9473265B2 (en) 2005-12-22 2016-10-18 Qualcomm Incorporated Methods and apparatus for communicating information utilizing a plurality of dictionaries
US20070243882A1 (en) 2006-04-12 2007-10-18 Qualcomm Incorporated Method and apparatus for locating a wireless local area network associated with a wireless wide area network
WO2008026349A1 (fr) * 2006-08-31 2008-03-06 Juridical Foundation Osaka Industrial Promotion Organization Agent thérapeutique destiné au traitement de l'effluvium télogène
PL2120917T3 (pl) * 2007-02-28 2014-09-30 Univ Kentucky Res Found Sposób na łagodzenie działań niepożądanych terapii kwasem retinowym i/lub ulepszanie skuteczności bez zakłócania skuteczności
JP2013516500A (ja) 2010-01-11 2013-05-13 ヒールオア・リミテッド 炎症性疾患および障害を治療するための方法
EP3446689B1 (en) * 2016-04-22 2025-01-08 JC (Wuxi) COMPANY, Inc. Isothiocyanate compound for use in the treatment of hyperbilirubinemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
DE3110611A1 (de) * 1981-03-18 1982-10-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
DE3570598D1 (en) * 1984-11-15 1989-07-06 Nitto Denko Corp Composition for percutaneous administration
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
JP2657583B2 (ja) * 1991-03-01 1997-09-24 ユニバーシテイ オブ フロリダ リサーチ ファンデーション インコーポレイテッド 神経系変性疾患の治療に対するニコチン類似体の利用
US5240945A (en) * 1992-02-18 1993-08-31 Warshaw Thelma G Method and compositions for treating acne
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
US5612382A (en) * 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
EP0815230A2 (en) * 1995-03-20 1998-01-07 Ligand Pharmaceuticals, Inc. MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
US6015821A (en) * 1995-05-01 2000-01-18 Horrobin; David Frederick Nicotinic acid esters and pharmaceutical compositions containing them
US20040102358A1 (en) * 1997-05-19 2004-05-27 Scivoletto Rosemarie Composition for treating skin conditions
AU4672199A (en) * 1998-05-20 1999-12-06 Yale University Modulation of angiogenesis and wound healing
DE69919403T2 (de) * 1998-12-01 2005-09-08 The University Of Kentucky Research Foundation Verwendung von nikotinsäurederivate zur behandlung von dna-schäden bei hautzellen
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6326034B1 (en) * 1999-12-22 2001-12-04 Natural Compounds Ltd Natural extracted and synthetic antioxidant compositions
WO2002072092A1 (en) * 2001-03-08 2002-09-19 University Of Kentucky Method for increasing leptin levels using nicotinic acid compounds

Similar Documents

Publication Publication Date Title
JP2004519488A5 (https=)
NO20045072L (no) Tablett med hoyt medikamentinnhold
HUS2000014I1 (hu) Glikopirrolátot és egy béta2 adrenoreceptor agonistát tartalmazó gyógyszerkészítmény
JP2008525445A5 (https=)
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
NO20064670L (no) Galeniske formuleringer av organiske forbindelser
JP2007512371A5 (https=)
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
CY1112401T1 (el) Παραγωγα πυριδαζινης
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
JP2005508371A5 (https=)
JP2003520232A5 (https=)
JP2012517449A5 (https=)
WO2006010546A3 (en) Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
MA29775B1 (fr) Derives de pyrazolone
ATE427926T1 (de) Cycloalkylaminderivate
JP2004002446A5 (https=)
JP2001511463A5 (https=)
JP2008515980A5 (https=)
JP2002537232A5 (https=)
MXPA02012038A (es) Analogos heterociclicos novedosos de compuestos de difeniletileno.
JP2009515927A5 (https=)
JP2004026743A5 (https=)
JP2002020783A5 (https=)
CA2615466A1 (en) Benzofused five-membered heterocycles as inhibitors of catechol-o-methyltransferase (comt) enzyme